Summary
Since many patients with a wide variety of diseases are nowadays stimulated to adopt a physically active lifestyle, the question of the influence of exercise on the pharmacokinetics of drugs has become more and more relevant. Because exercise influences a large number of physiological factors that also determine the pharmacokinetics of drugs, including haemodynamics, metabolism, pH, temperature and gastrointestinal function, it can be expected to have an effect on the pharmacokinetic parameters (absorption, distribution, elimination) of certain agents. However, only a very limited number of studies has been directed towards this issue, and only a very few drugs have been studied. Nevertheless, it is clear that exercise does influence the pharmacokinetics of certain drugs, although the magnitude and direction of the effects vary. This is not surprising in view of the widely differing physicochemical properties of drugs, the many possible — often opposing — effects of exercise on the parameters affecting drug pharmacokinetics and the different types of exercise performed.
The chance of a clinically relevant effect of exercise on the pharmacokinetics of a particular drug is largest in those with a steep dose-response curve, a narrow therapeutic range, a need for continuity of therapeutic effectiveness and a relatively short half-life, in combination with intensive exercise of long duration.
If untoward drug effects occur during or after exercise, a change in the pharmacokinetics of the drug related to the exercise should be seriously considered as a possible cause.
Similar content being viewed by others
References
Adams WC. Influence of exercise mode and selected ambient conditions on skin temperature. Annals of the New York Academy of Sciences 301: 110–127, 1977
Arends BG, Bohm ROB, van Kemenade JE, Rahn KH, von Baak MA. Influence of physical exercise on the pharmacokinetics of propranolol. European Journal of Clinical Pharmacology 31: 375–377, 1986
Aslaksen A, Aanderud L. Drug absorption during physical exercise. British Journal of Clinical Pharmacology 10: 383–385, 1980
Baak MA van, Mooij JMV, Schiffers PMH. Pharmacokinetics of antihypertensive drugs during exercise. Medicine and Science in Sports and Exercise 20 (Suppl.): S89, 1988
Ballard BE. Pharmacokinetics and temperature. Journal of Pharmaceutical Sciences 63: 1345–1358, 1974
Barkve TF, Langseth-Manrique K, Bredesen JE, Gjesdal K. Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. American Heart Journal 112: 537–541, 1986
Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P. Absorption kinetics and biologic effects of subcutancously injected insulin preparations. Diabetes Care 5: 77–91, 1982
Bowdle TA, Patel IH, Levy RH, Wilensky AJ. The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans. European Journal of Clinical Pharmacology 23: 343–347, 1982
Brouns F. Saris WHM. Rehrer NJ. Abdominal complaints and gastrointestinal function during long-lasting exercise. International Journal of Sports Medicine 8: 175–189, 1987
Castenfors J. Renal function during prolonged exercise. Annals of the New York Academy of Science 301: 151–159, 1977
Clausen JP. Effect of physical training on cardiovascular adjustment to exercise in man. Physiological Reviews 57: 779–815, 1977
Cordain L, Latin RW, Bchnke JJ. The effects of an anaerobic running program on bowel transit time. Journal of Sports Medicine 26: 101–104, 1986
Costill DL. Sweating: its composition and effects on body fluids. Annals of the New York Academy of Sciences 301: 160–174, 1977
Coyle JD, Lima JJ. Procainamide. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, pp. 682–711, Applied Therapeutics, Spokane, 1986
Danon A, Ben-Shimon S, Ben-Zvi Z. Effects of exercise and heat exposure on percutaneous absorption of methyl salicylate. European Journal of Clinical Pharmacology 31: 49–52, 1986
Døssing M. Effect of acute and chronic exercise on hepatic drug metabolism. Clinical Pharmacokinetics 10: 426–431, 1985
Felig P. Metabolic and endocrine disorders and exercise. In Bove et al. (Eds) Exercise medicine: physiological principles and clinical applications, pp. 305–320, Academic Press. New York. 1983
Fernqvist E, Linde B, Östman J, Gunnarsson R. Effect of physical exercise on insulin absorption in insulin-dependent diabetics: a comparison between human and porcine insulin. Clinical Physiology 6: 489–498, 1986
Fred HL. Reflections on a 100-mile run: effects of aspirin therapy. Medicine and Science in Sports and Exercise 1: 212–215, 1980
Gisolfi CV, Wenger CB. Temperature regulation during exercise: old concepts, new ideas. Exercise and Sport Sciences Reviews 12: 339–372, 1984
Gollnick PD, Bayly WM, Hodgson DR. Exercise intensity, training, diet and lactate concentration in muscle and blood. Medicine and Science in Sports and Exercise 18: 334–340, 1986
Hagenfeldt L. Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man. Diabetes 28 (Suppl. 1): 66–70, 1979
Henry JA, Iliopoulou A, Kaye CM, Sankey MG, Turner P. Changes in plasma concentrations of acebutolol, propranolol and indomethacin during physical exercise. Life Sciences 28: 1925–1929, 1981
Hurwitz GA, Webb JG, Walle T, Bai SA, Daniell HB, et al. Exercise-induced increments in plasma levels of propranolol and noradrenaline. British Journal of Clinical Pharmacology 16: 599–608, 1983
Jogestrand T, Andersson K. Effect of physical exercise on the pharmacokinelics of digoxin during maintenance treatment. Journal of Cardiovascular Pharmacology 14: 73–76, 1989
Jogestrand T, Sundqvist K. Effect of physical exercise on the digoxin concentrations in skeletal muscle and serum in man. Clinical Physiology 1: 99–104, 1981
Johnson JM. Regulation of skin circulation during prolonged exercise. Annals of the New York Academy of Sciences 301: 195–212, 1977
Joreteg T, Jogestrand T. Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity. European Journal of Clinical Pharmacology 25: 585–588, 1983
Joreteg T, Jogestrand T. Physical exercise and binding of digoxin to skeletal muscle — effect of activation frequency. European Journal of Clinical Pharmacology 27: 567–570, 1984
Kemmer FW, Berchtold P, Berger M, Starke A, Cüppers HJ, et al. Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes 28: 1131–1137, 1979
Kligman AM. A biological brief on percutaneous absorption. Drug Development and Industrial Pharmacy 9: 521–560, 1983
Klotz U, Lücke C. Physical exercise and disposition of diazepam. British Journal of Clinical Pharmacology 5: 349–350, 1978
Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. New England Journal of Medicine 298: 79–83, 1978
Linde B. Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site. Diabetes Care 9: 570–574, 1986
Lowenthal DT, Broderman SJ. The effects of exercise on genitourinary function. In Bove et al. (Eds) Exercise medicine: physiological principles and clinical applications, pp. 321–334, Academic Press, New York, 1983
Lüllmann H, Peters T. Action of cardiac glycosides on the excitation-contraction coupling in heart muscle. Progress in Pharmacology 2: 3–57, 1979
Lüllmann H, Peters T, Ziegler A. Kinetic events determining the effects of cardiac glycosides. Trends in Pharmacological Sciences 1: 102–106, 1979
McInnes GT, Brodie MJ. Concentration-effect relationships for oxprenolol in patients with essential hypertension. British Journal of Clinical Pharmacology 25: 539–545, 1988
Mason WD, Kochak G, Winer N, Cohen I. Effect of exercise on renal clearance of atenolol. Journal of Pharmaceutical Sciences 69: 344–345, 1980
Monks A, Richens A. Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. British Journal of Clinical Pharmacology 8: 187–188, 1979
Mooy J, Arends B, von Kemenade J. Böhm R, Rahn KH, Van Baak M. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans. Journal of Cardiovascular Pharmacology 8: 940–942, 1986
Mundie TG, Pamplin III CL, Phillips YY, Smallridge RC. Effect of exercise in sheep on the absorption of intramuscular atropine sulfate. Pharmacology 37: 132–136, 1988
Nadel ER. Recent advances in temperature regulation during exercise in humans. Federation Proceedings 44: 2286–2292, 1985
Patel IH, Levy RH. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90, 1979
Poortmans JR. Exercise and renal function. Exercise and Sport Sciences Reviews 5: 255–294, 1977
Powis G, Snow DH. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse. Journal of Pharmacology and Experimental Therapeutics 205: 725–731, 1978
Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiological Reviews 54: 75–159, 1974
Saltin B, Hermansen L. Esophageal, rectal, and muscle temperature during exercise. Journal of Applied Physiology 21: 1757–1762, 1966
Schlaeffer F, Engelberg I, Kaplanski J, Danon A. Effects of exercise and environmental heat on theophylline kinetics. Respiration 45: 438–442, 1984
Simko V. Physical exercise and the prevention of atherosclerosis and cholesterol gall stones. Postgraduale Medical Journal 54: 270–277, 1978
Smolander J, Kolari P, Korhonen O, Ilmarinen R. Skin blood flow during incremental exercise in a thermoneutral and hot dry environment. European Journal of Applied Physiology 56: 273–280, 1987
Swartz RD, Sidell FR. Effects of heal and exercise on the elimination of pralidoxime in man. Clinical Pharmacology and Therapeutics 14: 83–89, 1973
Swartz RD, Sidell FR, Cucinell SA. Effects of physical stress on the disposition of drugs eliminated by the liver in man. Journal of Pharmacology and Experimental Therapeutics 188: 1–7, 1974
Sweeney GD. Drugs — some basic concepts. Medicine and Science in Sports and Exercise 13: 247–251, 1981
Theilade P, Hansen JM, Skovsted L, kampmann JP. Effect of exercise on thyroid parameters and on metabolic clearance rate of antipyrine in man. Ada Endocrinologica 92: 271–276, 1979
Verstappen FTJ. Van Baak MA. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade: comparison between a beta l-selective and a non-selective beta blocker. European Journal of Applied Physiology 56: 712–718, 1987
Weber S, de Lauture D, Rey E, Darragon I, Severins JP, et al. The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine. British Journal of Clinical Pharmacology 23: 103–105, 1987
Ylitalo P, Hinkka H. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide. International Journal of Clinical Pharmacology Therapeutics and Toxicology 23: 548–553, 1985
Ylitalo P, Hinkka H, Neuvonen PJ. Effect of exercise on the serum level and urinary excretion of letracycline, doxycycline and sulphamcthizole. European Journal of Clinical Pharmacology 12: 367–373, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Baak, M.A. Influence of Exercise on the Pharmacokinetics of Drugs. Clin Pharmacokinet 19, 32–43 (1990). https://doi.org/10.2165/00003088-199019010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199019010-00003